Cameco Corp. (NYSE:CCJ)’s traded shares stood at 3.5 million during the last session, with the company’s beta value hitting 0.90. At the close of trading, the stock’s price was $53.79, to imply a decrease of -0.11% or -$0.06 in intraday trading. The CCJ share’s 52-week high remains $58.72, putting it -9.17% down since that peak but still an impressive 34.13% since price per share fell to its 52-week low of $35.43. The company has a valuation of $23.41B, with an average of 5.79 million shares in intraday trading volume over the past 10 days and average of 4.66 million shares over the past 3 months.

Analysts have given a consensus recommendation of Buy for Cameco Corp. (CCJ), translating to a mean rating of 1.19. Of 5 analyst(s) looking at the stock, 0 analyst(s) give CCJ a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.18.

Cameco Corp. (NYSE:CCJ) trade information

After registering a -0.11% downside in the last session, Cameco Corp. (CCJ) has traded red over the past five days. The 5-day price performance for the stock is -7.29%, and 11.92% over 30 days. With these gigs, the year-to-date price performance is 24.80%. Short interest in Cameco Corp. (NYSE:CCJ) saw shorts transact 18.76 million shares and set a 4.17 days time to cover.

The extremes give us $30.23840614 and $55 for target low and target high price respectively. As such, CCJ has been trading -2.25% off suggested target high and 43.78% from its likely low.

Cameco Corp. (CCJ) estimates and forecasts

Looking at statistics comparing Cameco Corp. share performance against respective industry, we note that the company has outperformed competitors. Cameco Corp. (CCJ) shares are 9.00% up over the last 6 months, with its year-to-date growth rate higher than industry average at 45.61% against 15.30%. Revenue is forecast to shrink -25.00% this quarter before jumping 86.70% for the next one. The rating firms project that company’s revenue will grow 14.10% compared to the previous financial year.

Revenue forecast for the current quarter as set by 3 analysts is 535.1M. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 749.2M.

CCJ Dividends

Cameco Corp. has its next earnings report out on 2024-Nov-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Cameco Corp. has a forward dividend ratio of 0.09, with the share yield ticking at 0.16% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.36%.

Cameco Corp. (NYSE:CCJ)’s Major holders

Cameco Corp. insiders hold 0.16% of total outstanding shares, with institutional holders owning 78.60% of the shares at 78.72% float percentage. In total, 78.60% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 37.72 million shares (or 10.6914% of shares), all amounting to roughly $1.86 billion.

The next major institution holding the largest number of shares is MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. with 17.24 million shares, or about 4.8852% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $847.84 million.

We also have Global X Fds-Global X Uranium ETF and Capital World Growth and Income Fund as the top two Mutual Funds with the largest holdings of the Cameco Corp. (CCJ) shares. Going by data provided on Sep 30, 2024 , Global X Fds-Global X Uranium ETF holds roughly 16.25 shares. This is just over 3.73% of the total shares, with a market valuation of $873.99 million. Data from the same date shows that the other fund manager holds a little less at 11.41, or 2.62% of the shares, all valued at about 613.83 million.